Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas

Hepato-Gastroenterology

Volumn 54, Issue 78, 2007, Pages 1635-1640

  Jinfeng, Ma ^a   Kimura, Wataru ^a,b   Sakurai, Fumiaki ^a   Moriya, Toshiyuki ^a   Mizutani, Masaomi ^a   Hirai, Ichiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Ductal adenocarcinoma of the pancreas; Intratumoral microvessel density; p53; Thymidine phosphorylase

Indexed keywords

PROTEIN P53; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROGNOSIS; THYMIDINE PHOSPHORYLASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 35948973980     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
2. Bouck N: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cell 1990; 2:179-185.
3. Folkman J, Watson K, Ingber D, Hanahan D: Introduction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61.
4. Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical application of research on angiogenesis. N Engl J Med 1995; 333:1757-1763.
5. Hanahan D, Folkman J: Pattern and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
6. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K: Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996; 77(8 Suppl):1722-1728.
7. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, Muraoka R, Tanaka T: Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 1997; 79:220-225.
8. Giatromanolaki A, Sivridis E, Koukourakis MI, Polychronidis A, Simopoulos C: Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J Clin Oncol 2002; 25:38-41.
9. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S, Aikou T: The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 1996; 32A:1227-1232.
10. Iltzsch MH, el-Kouni MH, Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985; 24:6799-6807.
11. Krenitsky TA, Koszalka GW, Tuttle JV: Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylase. Biochemistry 1981; 20:3615-3621.
12. Zimmerman M, Seidenberg J: Deoxyribosyl transfer. J Biol Chem 1964; 239:2618-2621.
13. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem (Tokyo) 1993; 114:9-14.
14. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y: Angiogenic activity of enzymes. Nature (Lond.) 1994; 368:198.
15. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH: Dentification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.) 1989; 338:557-562.
16. Zhao B, Kimura W, Futakawa N, Abe H, Kitayama J, Nagawa H, Makuuchi M: Significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in Carcinoma of the Papilla of Vater. Jpn J Cancer Res 2000; 91:331-336.
17. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Harris AC: Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997; 75:477-481.
18. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T, Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996; 87:288-295.
19. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88:1110-1117.
20. Takao S, Takebayshi Y, Che X, Shinchi H, Natsugoe S, Miyadera K, Yamada Y, Akiyama S, Aikou T: Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998; 4:1619-1624.
21. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995; 64:79-82.
22. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995; 55:510-513.
23. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bickneel R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995; 92:998-1002.
24. Nakagawa S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K: Tumor angiogenesis as an independent prognostic factor after extended radical esophagectomy for invasive squamous cell carcinoma of the esophagus. Surgery 2001; 129:302-308.
25. Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y: Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995; 18:197-206.
26. Kimura W, Sata N, Nakayama H, Muto T, Matsuhashi N, Sugano K, Atomi Y: Pancreatic carcinoma accompanied by pseudocyst: report of two cases. J Gastroenterol 1994; 29:786-791.
27. Kimura W, Sasahira N, Yoshikawa T, Muto T, Makuuchi M: Duct-ectatic type of mucin producing tumor of the pancreas - new concept of pancreatic neoplasia. Hepatogastroenterology 1996; 43:692-709.
28. Kimura W, Morikane K, Esaki Y, Chan WC, Pour PM: Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy. Cancer 1998; 82:1839-1849.
29. Jinfeng M, Kimura W, Hirai I, Sakurai F, Moriya T, Mizutani M: Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis. Int J Gastrointest Cancer 2003; 34:9-18.
30. Jinfeng M, Kimura W, Sakurai F, Moriya T, Takeshita A, Hirai I: Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT. Int J Gastrointest Cancer. 2002; 32:73-81.
31. Kieser A, Weich HA, Brandner G, Marme D, Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9:963-969.
32. Mukhopadhyay D, Tsiokas L, Sukhatme VP: Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55:6161-6165.
33. Sobin LH, Wittekind CH, et al. (Eds.): TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss, 1997.
34. Filder IJ, Ellis LM: The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79:185-188.
35. Terai Y, Ueda M, Kumagai K, Ueki K, Ueki M: Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum. Int J Gynecol Pathol 2000; 19:354-360.
36. Ueda M, Terai Y, Kumagai K, Ueki K, Okamoto Y, Ueki M: Correlation between tumor angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma. Hum Pathol 1999; 30:1389-1394.
37. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N: The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998; 82:1225-1232.
38. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992; 267:10931-10934.
39. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-915.
40. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51:6304-6311.
41. Lane DP: p53 guardian of the genome. Nature 1992; 358:15-16.